Next Article in Journal
Coupling Osmotic Efficacy with Biocompatibility in Peritoneal Dialysis: A Stiff Challenge
Previous Article in Journal
Plasma and Platelet Brain-Derived Neurotrophic Factor (BDNF) Levels in Bipolar Disorder Patients with Post-Traumatic Stress Disorder (PTSD) or in a Major Depressive Episode Compared to Healthy Controls
Previous Article in Special Issue
Suppression of Borna Disease Virus Replication during Its Persistent Infection Using the CRISPR/Cas13b System
 
 
Review
Peer-Review Record

Human–Fungal Pathogen Interactions from the Perspective of Immunoproteomics Analyses

Int. J. Mol. Sci. 2024, 25(6), 3531; https://doi.org/10.3390/ijms25063531
by Tanaporn Wangsanut * and Monsicha Pongpom
Reviewer 1: Anonymous
Reviewer 2:
Int. J. Mol. Sci. 2024, 25(6), 3531; https://doi.org/10.3390/ijms25063531
Submission received: 8 February 2024 / Revised: 15 March 2024 / Accepted: 15 March 2024 / Published: 20 March 2024
(This article belongs to the Special Issue Recent Therapeutic Strategies against Infectious Agents)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

The authors have prepared a comprehensive review of the relevant data supporting the human-fungal pathogen interactions. This review is a good contribution to the field and summarizes a large set of studies concisely and clearly. I have included only a few comments.

1. The manuscript does a nice job describing the comprehensive set of potential human-fungal interactions that could be exploited to generate new therapeutics, vaccines or diagnostics. There is reference to a few that have been tried, but no specific section on these attempts and the successes and failures. Did the authors consider if adding a bit more detail on this?

2. Line 187, it states "significance of identified antigenic proteins in the legend; however, should this be the proteins identified or the method to identify the proteins, based on the information in the figure?

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

This review provided comprehensive information regarding to antigenic proteins in medically important fungi for preventive, vaccination and therapeutic strategies against fungal emerging infections.Bellow, some comments might help to increase the importance of this study.

1.Considering antibodies to fight antigenic proteins also might react some human antigens as a cross reaction, how do you explain the therapeutic effect of those antibody to treat fungal infections?

2.Are there in vivo(animal models)used some of antigenic proteins of fungal species to eliminate fungal infections in review literature with specific function?If soothe authors should include this part in the review.

3.Table 3,antigenic proteins list  for H.capsulatum is too long list, it would be more appealing to summarise it only the main antigens and for others just mention the relevant references in the text.

4.the authors illuminated  many antigens for different fungal species ,it is recommended for each species importantly focused on the most substantial ones based on the literature, especially for those included in invite mice models with therapeutic approach to eradicate fungal load from infected tissue.

 

 

Comments on the Quality of English Language

To improve the English quality of paper, edition by Native English speaker is recommended throughout the text.

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Back to TopTop